Association between atopic dermatitis in early childhood and increased risk for inflammatory bowel disease

in early childhood is associated with an increased risk for inflammatory bowel disease later in life, but atopic manifestations are generally not associated with IBD.Studies examining the link between atopy and IBD have yielded inconsistent results. Many of these studies included adults, introducing recall bias, or relied on physician diagnoses that might have overlooked mild cases.

Researchers analyzed prospectively collected data on 83,311 children from two cohort studies, ABIS and MoBa , who were followed up from birth until 2021 or a diagnosis of IBD. Information on parents was collected prospectively via questionnaires on any atopy their children might have developed by the age of 3 years. Atopy included conditions such as AD,A total of 301 participants were diagnosed with IBD over 1,174,756 person-years of follow-up. By the age of 3 years, 31,671 children were reported to have any atopic manifestation.

Source: Healthcare Press (healthcarepress.net)

Atopic Dermatitis Inflammatory Bowel Disease Childhood Cohort Study Risk Factor

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Updated Guidance Supports FMT for CDI, But Not IBD or IBSBased on a synthesis of best available evidence, the AGA released clinical recommendations on fecal microbiota-based therapies in adults with gastrointestinal diseases.
Source: Medscape - 🏆 386. / 55 Read more »

No Benefit to Combo Tx to Prevent Recurrent C diff in IBDGiven the high efficacy of fecal microbiota transplantation, adding bezlotoxumab may not provide further reduction in recurrence.
Source: Medscape - 🏆 386. / 55 Read more »

How COVID-19 Treatments Affect Patients With IBDInflammatory bowel disease therapies for patients may need to be briefly halted during treatment for COVID-19, but it does not increase flares.
Source: Medscape - 🏆 386. / 55 Read more »

No Clear Benefit to Combination Treatment to Prevent Recurrent C difficile in IBDGiven the high efficacy of fecal microbiota transplantation, adding bezlotoxumab may not provide further reduction in recurrence.
Source: Medscape - 🏆 386. / 55 Read more »

Patients With IBD at Increased Risk for MyocarditisPatients with IBD had a higher risk for myocarditis, especially severe myocarditis, than the general population, according to the results of a Swedish Cohort Study.
Source: Medscape - 🏆 386. / 55 Read more »

Patients with IBD at Higher Risk for Myocarditis, Study FindsPatients with inflammatory bowel disease (IBD) have a higher risk for myocarditis, especially severe myocarditis, than the general population, even 20 years after diagnosis, although absolute risks are low.
Source: Medscape - 🏆 386. / 55 Read more »